Skip to main content

Advertisement

Log in

UPLC-Q-Orbitrap HRMS Analysis of Coptis chinensis Aerial Parts and Its Regulatory Activity on Glucose-lipid Metabolism

  • Original Article
  • Published:
Revista Brasileira de Farmacognosia Aims and scope Submit manuscript

Abstract

Coptis chinensis Franch., Ranunculaceae, is a widely used herbal medicine in Asian countries. It exhibits many important pharmacological effects. The rhizome is used as the crude drug for this medicinal plant. The objective of this study was to determine whether the aerial part (stem and leaves) can be employed as a complementary material for medicinal purposes. Ultraperformance liquid chromatography coupled to a hybrid quadrupole-orbitrap high-resolution mass spectrometry analysis was applied to detect fifteen alkaloids. Network pharmacology analysis indicated that these compounds might interact with important glucose-lipid metabolism–related targets. Appropriate dose of streptozotocin and high-fat diet were used to establish the model of glucose-lipid disorder in Kunming mice. Blood glucose level was determined by handheld blood glucose meter. Peroxidase antiperoxidase kit was used to test the serum total cholesterol and triacylglyceride level. Hematoxylin/eosin staining was performed to analyze the degree of damage in the liver and kidney. Our data demonstrated that aerial part contained a similar chemical composition with the crude drug. Network pharmacology analysis and animal experiments also indicated that extracts from the aerial parts exhibited a good glucose-lipid metabolism regulatory activity.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Download references

Acknowledgments

All authors are grateful to their affiliation institutions which provided research conditions and access to analytical instrumentations.

Funding

Financial support was supported by the Department of Science and Technology of Sichuan Province (2020YFS0498) and the Chengdu University of Traditional Chinese Medicine Key Laboratory of Systematic Research of Distinctive Chinese Medicine Resources in Southwest China (2020JCRC015).

Author information

Authors and Affiliations

Authors

Contributions

GL: design of the experimental animal model and pharmacology; ZY and HY: plant material extraction; HJ and QG: network pharmacology analysis; CP and HX: mass spectrometry analysis, drafting the manuscript, and constructed the figures and tables; Q.H: critical revision of the manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Qinwan Huang.

Ethics declarations

All experiments were performed consistent with animal use followed by Chengdu University of Traditional Chinese Medicine of Laboratory Animal Ethics Committee. Ethical approval number: 2020-05.

Conflict of Interest

The authors declare that they have no conflicts of interest.

Animal Ethical Approval

All experiments were performed in compliance with international rules on the care and use of laboratory animals. The study was approved by the Chengdu University of Traditional Chinese Medicine Laboratory Animal Ethics Committee. Ethical protocol number: 2020-05.

Supplementary Information

ESM 1

(PDF 898 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lou, G., Xiong, H., Gan, Q. et al. UPLC-Q-Orbitrap HRMS Analysis of Coptis chinensis Aerial Parts and Its Regulatory Activity on Glucose-lipid Metabolism. Rev. Bras. Farmacogn. 31, 24–31 (2021). https://doi.org/10.1007/s43450-020-00124-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43450-020-00124-3

Keywords

Navigation